Literature DB >> 761185

Determination of [3H]- and [14C]hematoporphyrin derivative distribution in malignant and normal tissue.

C J Gomer, T J Dougherty.   

Abstract

The synthesis and tissue-localizing ability of [14C]- and [3H]hematoporphyrin derivative (HPD) in mice have been described. Tissue levels and distributions were the same for both radioactive compounds, indicating that in vivo tritium exchange did not occur with [3H]HPD. The amount of [14C]HPD or [3H]HPD which localized in the transplanted tumor tissue of mice at various times following i.p. injection (10 mg/kg) was higher than in skin or muscle tissue but was less than in liver, kidney, or spleen tissue. These results tend to disprove the generalization that HPD accumulates in malignant tissue to a higher degree than in all normal tissue. It is also reported that gross visualization of porphyrin fluorescence cannot be correlated with actual tissue concentrations of the dye.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 761185

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  67 in total

1.  Response of human endometrium and ovarian carcinoma cell-lines to photodynamic therapy.

Authors:  G H Raab; A F Schneider; W Eiermann; H Gottschalk-Deponte; R Baumgartner; W Beyer
Journal:  Arch Gynecol Obstet       Date:  1990       Impact factor: 2.344

Review 2.  Imaging and photodynamic therapy: mechanisms, monitoring, and optimization.

Authors:  Jonathan P Celli; Bryan Q Spring; Imran Rizvi; Conor L Evans; Kimberley S Samkoe; Sarika Verma; Brian W Pogue; Tayyaba Hasan
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

3.  The role of interventional pulmonary procedures in the management of post-obstructive pneumonia.

Authors:  Ravindra M Mehta; Michael Cutaia
Journal:  Curr Infect Dis Rep       Date:  2006-05       Impact factor: 3.725

4.  The ratio of the spherical and flat Detectors at tissue surfaces during pleural photodynamic therapy.

Authors:  Timothy C Zhu; Joseph S Friedberg; Andrea Dimofte; Jeremy Miles; James Metz; Eli Glatstein; Stephen M Hahn
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2002-06-06

5.  Photodynamic therapy for malignant tumours of the ampulla of Vater.

Authors:  A M Abulafi; J T Allardice; N S Williams; N van Someren; C P Swain; C Ainley
Journal:  Gut       Date:  1995-06       Impact factor: 23.059

6.  Possible advantages of aluminum-chloro-tetrasulfonated phthalocyanine over hematoporphyrin derivative as a photosensitizer in photodynamic therapy.

Authors:  K Koshida; H Hisazumi; K Komatsu; A Hirata; T Uchibayashi
Journal:  Urol Res       Date:  1993

7.  Peptide analogues alter the progression of premalignant lesions, as measured by Photofrin fluorescence.

Authors:  C Liebow; D H Crean; A V Schally; T S Mang
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

8.  Selective incorporation of 111In-labeled PHOTOFRIN by glioma tissue in vivo.

Authors:  H T Whelan; L H Kras; K Ozker; D Bajic; M H Schmidt; Y Liu; L A Trembath; F Uzum; G A Meyer; A D Segura
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

9.  Endoscopic photodynamic therapy with hematoporphyrin derivative for primary treatment of gastrointestinal neoplasms in inoperable patients.

Authors:  T Patrice; M T Foultier; S Yactayo; F Adam; J P Galmiche; M C Douet; L Le Bodic
Journal:  Dig Dis Sci       Date:  1990-05       Impact factor: 3.199

10.  Ascorbate-enhanced lipid peroxidation in photooxidized cell membranes: cholesterol product analysis as a probe of reaction mechanism.

Authors:  G J Bachowski; J P Thomas; A W Girotti
Journal:  Lipids       Date:  1988-06       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.